Publications

Publications

Filter Results: (1,012) Arrow Down
Filter Results: (1,012) Arrow Down Arrow Up

Show Results For

Show Results For

← Page 13 of 1,012 Results →
  • 2023
  • Working Paper

Market Exclusivity and Innovation: Evidence From Antibiotics

By: Edward Kong and Olivia Zhao
The US incentivizes drug innovation via patents as well as market exclusivity periods awarded by the US Food and Drug Administration. We estimate the causal effects of extending market exclusivity for an important drug class: antibiotics. Using a... View Details
Keywords: Health Testing and Trials; Innovation and Invention; Motivation and Incentives; Government Administration; Government Legislation; Pharmaceutical Industry; United States
Related
  • 08 Aug 2017
  • First Look

First Look at Research and Ideas, August 8, 2017

trials at Boston Children’s Hospital. As the founders prepare to bring their new medical device to market, they struggle with two key decisions: Should Luminopia create its own salesforce to sell its product or should it outsource? View Details
Keywords: Sean Silverthorne
  • 08 Dec 2003
  • Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily... View Details
Keywords: by Sean Silverthorne; Health; Health; Health; Health
  • 2013
  • Working Paper

What Makes the Bonding Stick? A Natural Experiment Involving the U.S. Supreme Court and Cross-Listed Firms

By: Amir N. Licht, Christopher Poliquin, Jordan I. Siegel and Xi Li
On March 29, 2010, the U.S. Supreme Court signaled its intention to geographically limit the reach of the U.S. securities antifraud regime and thus differentially exclude U.S.-listed foreign firms from the ambit of formal U.S. antifraud enforcement. We use this legal... View Details
Keywords: Crime and Corruption; International Finance; Investment; Corporate Governance; Governing Rules, Regulations, and Reforms; Courts and Trials; Legal Liability; United States
Related
  • 31 Jul 2018
  • Working Paper Summaries

How Does Product Liability Risk Affect Innovation? Evidence from Medical Implants

Keywords: by Alberto Galasso and Hong Luo
  • 2014
  • Working Paper

Bio-Piracy or Prospering Together? Fuzzy Set and Qualitative Analysis of Herbal Patenting by Firms

By: Prithwiraj Choudhury and Tarun Khanna
Since the 1990s, several Western firms have filed patents based on medicinal herbs from emerging markets, evoking protests from local stakeholders against 'bio-piracy'. We explore conditions under which firms and local stakeholders share rents from such patents. Our... View Details
Keywords: Rents From New Technology; Local Stakeholders; Herbal Patents; QCA; Fuzzy Set Analysis; Qualitative Case Studies; Plant-Based Agribusiness; Patents; Emerging Markets; Health Care and Treatment; Business and Stakeholder Relations; Cross-Cultural and Cross-Border Issues; Agriculture and Agribusiness Industry; Agriculture and Agribusiness Industry
Related
  • October 2021 (Revised January 2022)
  • Supplement

Michael Ku and Global Clinical Supply at Pfizer Inc.: Bringing Hope to Patients (C)

By: Linda A. Hill and Emily Tedards
This case is the third installment in a series about the 10-year cultural and digital transformation of Pfizer’s Global Clinical Supply organization. In 2011, Michael Ku became Pfizer’s Vice President of Global Clinical Supply (GCS) after the company had undergone... View Details
Keywords: Clinical Supply Chain; COVID-19; Vaccine; Agile; Innovation and Invention; Change Management; Organizational Culture; Transformation; Leadership; Corporate Strategy; Health Pandemics; Crisis Management; Mission and Purpose; Health Care and Treatment; Supply Chain Management; Digital Transformation
Related
  • September 2017
  • Case

Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry

By: Steven Rogers and Alyssa Haywoode
Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine... View Details
Keywords: Dr. Williams Carson; Otsuka America Pharmaceutical; Harvard; Abilify; Aripiprazole; Health Testing and Trials; Globalized Firms and Management; Globalized Markets and Industries; Cross-Cultural and Cross-Border Issues; Decision Choices and Conditions; Pharmaceutical Industry; Japan
Related
  • 03 Oct 2023
  • Research Event

Build the Life You Want: Arthur Brooks and Oprah Winfrey Share Happiness Tips

community too. Like I'm a Harvard professor and I'm darn proud of it. Will this represent you in a way that you'll say, that was a good thing that we did as a community for this world. Will we bring Harvard University to the world View Details
Keywords: by HBS Staff
  • 15 Jun 2021
  • News

June 2021 Books and Podcasts

investing and development in “the toughest business in the world” in four acts. Along the way, he offers a compassionate, interdisciplinary perspective on philosophical questions ranging from art and urban... View Details
Keywords: Margie Kelley; Publishing Industries (except Internet); Information
  • 21 Jun 2010
  • Research & Ideas

Strategy and Execution for Emerging Markets

reasonable prices are in demand. One example: In health care, GE is producing a computerized tomography (CT) scan machine that is functional without a lot of bells and whistles. It was designed originally... View Details
Keywords: by Martha Lagace
  • Web

Aligning Reimbursement with Value - Institute For Strategy And Competitiveness

Measure Outcomes & Cost for Every Patient Aligning Reimbursement with Value Systems Integration Geography of Care Information Technology Aligning Reimbursement w... Aligning Reimbursement with Value Value-based health care delivery... View Details
  • August 2013
  • Course Overview Note

Building Life Science Businesses Fall 2013: Course Outline and Syllabus

By: Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses. View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Related
  • September 2012 (Revised September 2012)
  • Course Overview Note

Building Life Science Businesses Fall 2012: Course Outline and Syllabus

By: Richard G. Hamermesh and Richard G. Hamermesh
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses View Details
Keywords: Healthcare Ventures; Entrepreneurial Management; Entrepreneurship; Entrepreneurs; Health Care and Treatment; Health Testing and Trials; Medical Specialties; Health Industry; Health Industry; Health Industry; Asia; North America; Europe
Related
  • 12 Jun 2018
  • First Look

New Research and Ideas, June 12, 2018

technology, but these results are driven almost entirely by heterogeneous effects by those with and without computer science and engineering (CS&E) backgrounds. Specifically, View Details
Keywords: Dina Gerdeman
  • 23 Jun 2022
  • Research & Ideas

All Those Zoom Meetings May Boost Connection and Curb Loneliness

remote work. “There’s a huge value to real interactions even if they are occurring virtually,” says Goldenberg, who is a psychologist by training and an assistant professor at HBS. To test online... View Details
Keywords: by Michael Blanding
  • 01 Dec 2020
  • News

New Releases: Alumni and Faculty Books

Bertini (DBA 2006) and Oded Koenigsberg The MIT Press Would you rather pay for health care or for better health? For school or education? For groceries or nutrition? A car or transportation? A theater... View Details
Keywords: Margie Kelley
  • 2008
  • Chapter

The Evidence Does Not Speak for Itself: Expert Witnesses and the Organization of DNA-Typing Companies

By: Arthur A. Daemmrich
During the past 15 years, new biotechnology companies have promoted DNA typing as a sophisticated criminal and paternity identification technique. Private testing laboratories produce results that link individuals with crime scenes and fathers to their children.... View Details
Keywords: Governing Rules, Regulations, and Reforms; Courts and Trials; Organizational Structure; Practice; Genetics; Science-Based Business; Trust; Commercialization; Vertical Integration
Related
  • 01 Jun 2018
  • News

June 2018 Alumni and Faculty Books

Innovation in Health Care: How to Make Value-Based Delivery Work by Vijay Govindarajan (DBA 1978) and Ravi Ramamurti (DBA 1982) HBR Press Though still a pipe dream in the US, value-based competition (value... View Details
  • Web

Stata Temporary Files and Stata Tmp - Research Computing Services

a number of files on the /tmp volume that is local to each compute node. This volume is shared by all jobs on that node, is essential for the health of the node, offers a significant speed advantage over using storage on the network,... View Details